Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $956,340 - $1.21 Million
13,200 Added 3300.0%
13,600 $1.09 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $32,495 - $38,948
400 New
400 $33,000
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $163,480 - $240,680
-2,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $166,500 - $204,240
2,000 New
2,000 $175,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.51B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.